​New Breakthrough in Haemophilia Treatment

Recently, Indian researchers have successfully developed a gene therapy treatment for severe haemophilia A, showing promising results in a trial, with five patients reporting no bleeding episodes for over a year.

The findings have been published in a peer-reviewed journal in December 2024.

  • The gene therapy trial was conducted on five patients in Tamil Nadu, who have not reported any bleeding episodes for an average follow-up period of 14 months.
  • The treatment uses a lentivirus vector to introduce the clotting factor gene, which is considered a safer alternative to the adenovirus vector used in Roctavian, a gene therapy approved by ....

Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy February 2025 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Related Content

Science & Technology